A national clinical trial for an unorthodox drug to treat a cancer that strikes very young children now has openings in New Jersey, thanks to a foundation.
The Phase 2 trial for a medication to treat neuroblastoma recently added Hackensack University Medical Center as a research site – one of only two East Coast research sites between Connecticut and Washington, D.C.
The drug in question is typically given to treat African sleeping sickness, but has already been shown to reduce tumors in mice. An earlier phase of the clinical trial also proved it safe enough for study in humans.
Read Full Article Here >>